A study of an experimental drug for advanced solid tumors
Part of Cancer, Digestive system, Women’s health & pregnancy clinical trials.
This trial tests a new drug, ST-01156, designed to attack cancer cells by breaking down a protein called RBM39. It may be an option for people with advanced solid tumors that have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older (or 16 or older if you have Ewing sarcoma or a similar cancer).
- You must have a solid tumor that has spread or cannot be removed with surgery.
- Your tumor must be measurable on scans or show signs of disease.
- You must be able to care for yourself and be up and about more than half of the day (ECOG score 0-2).
- Your organs must be working well enough, as determined by standard blood and urine tests.
- You cannot have had chemotherapy, radiation, or other cancer treatments within the last 2 weeks (or longer for some drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called HRS-3802 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and how the body processes it.
This trial tests a new drug, BTM-3566, for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests a new drug called SCTB39G for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can help shrink or control the cancer.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
Hear when a new Ewing Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.